| __timestamp | BeiGene, Ltd. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 21862000 | 8901000 |
| Thursday, January 1, 2015 | 58250000 | 9574000 |
| Friday, January 1, 2016 | 98033000 | 14695000 |
| Sunday, January 1, 2017 | 273992000 | 8437000 |
| Monday, January 1, 2018 | 707710000 | 12723000 |
| Tuesday, January 1, 2019 | 998528000 | 51272000 |
| Wednesday, January 1, 2020 | 1365534000 | 50052000 |
| Friday, January 1, 2021 | 1624145000 | 783000 |
| Saturday, January 1, 2022 | 1926983000 | 868000 |
| Sunday, January 1, 2023 | 379920000 | 123740000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for BeiGene, Ltd. and Geron Corporation from 2014 to 2023. Over this period, BeiGene's cost of revenue surged by approximately 8,700%, peaking in 2022, before a notable decline in 2023. In contrast, Geron Corporation maintained a more stable trajectory, with a significant spike in 2023, marking a 1,300% increase from its 2014 figures.
The data reveals BeiGene's aggressive expansion strategy, reflected in its rising costs, while Geron's steadier approach suggests a focus on sustainable growth. This comparison offers valuable insights into the strategic priorities of these biotech giants, highlighting the diverse paths companies can take in the pursuit of innovation and market leadership.
Cost Insights: Breaking Down Novo Nordisk A/S and BeiGene, Ltd.'s Expenses
Cost of Revenue Trends: Sanofi vs BeiGene, Ltd.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs BeiGene, Ltd.
BeiGene, Ltd. vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
BeiGene, Ltd. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down BeiGene, Ltd. and Dyne Therapeutics, Inc.'s Expenses
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Geron Corporation
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Cost of Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Geron Corporation
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored